EGFR and non-small cell lung carcinoma: Because macroautophagy is also induced by epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs), which are molecular target drugs for NSCLC patients with sensitive EGFR mutations, autophagy is expected to be a new therapeutic target in the treatment of NSCLC independent of EGFR expression.11, 12